Target intelligence / Profile preview

RNA, U6 small nuclear 333, pseudogene (RNU6-333P)

Target
RNU6-333P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNA, U6 small nuclear 333, pseudogene (RNU6-333P) is a **pseudogene** related to the U6 small nuclear RNA gene family. U6 small nuclear RNAs are components of the spliceosome, the ribonucleoprotein complex essential for precursor mRNA splicing. However, as a pseudogene, RNU6-333P is regarded as a non-functional, non-coding segment of genomic DNA that arose from duplication or retrotransposition of a functional U6 RNA gene but has lost the ability to encode a functional RNA product. Most small nuclear RNA pseudogenes like RNU6-333P are presumed to be unexpressed and play no known biological role[1][3][5]. There is no evidence that this particular pseudogene encodes a protein, participates in regulatory processes, is a drug target, or plays a role in disease pathology. - The "is_incorrect" flag is set to true because pseudogenes like RNU6-333P are generally not considered molecular or therapeutic targets, and there is no evidence of functional relevance, pharmacological targeting, or disease association for this entry[2][3]. - No aliases beyond the systematic symbol RNU6-333P are reported[3][5]. - No relevant drugs, mechanisms of action, biomarker use, or safety concerns are associated with this pseudogene, reflecting its lack of molecular and clinical significance[3][5].

Other names
RNU6-333P

Beyond the preview

Go deeper on RNA, U6 small nuclear 333, pseudogene (RNU6-333P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 333, pseudogene (RNU6-333P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call